Track the Diagnostyka S.A. share price and the full insider trade history of the company, a publicly traded company based in Poland. Shares are listed on the PL market, under the authority of KNF. Operating in the Health Care sector, Diagnostyka S.A. has logged 3 insider filings. Market capitalisation: €5.7bn. The latest transaction was reported on 18 May 2026 (Notification PDMR). All data is accessible without an account.
Analysts rate Diagnostyka S.A. Buy (bullish), based on 6 analysts. Average price target: PLN 197.45.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Diagnostyka S.A. is a company specializing in the healthcare and pharmaceutical sector, providing medical diagnostic services. It is listed on the XWAR market.